Based in Boston, RA Capital Management is an investment advisor that specializes in the life-sciences and drug development sectors. With a team of professionals who possess training in biology, chemistry, and medicine, as well as executive and board-level experience in industry and business development, the company has been investing since 2002. RA Capital Management's investment strategy focuses on identifying companies with promising technologies and products, and achieving a superior understanding of data, experimental/trial design, regulatory process, and commercial potential. In addition, the company offers in-licensing opportunities, strategic partnership leads, and insights into the demands of public markets to its portfolio companies, as appropriate.
340
Total Investments
245
Portfolio Companies
-
Exits
3
Industries
General Information
Industries
Biotechnology, Finance +1
Funding Stage
Seed +3
Company Overview
Investment Criteria
Investment Thesis
•••••• •••••• ••••••
About RA Capital Management
Recent Investments (340)
View All| Company | Stage | Amount | Date |
|---|---|---|---|
| Series C | •••••• | Apr 2026 | |
| Series B | •••••• | Apr 2026 | |
| Series A | •••••• | Mar 2026 | |
| Private Placement Non Vc | •••••• | Mar 2026 | |
| Series B | •••••• | Mar 2026 | |
|
|
Series B | •••••• | Mar 2026 |
|
|
Post Ipo Equity | •••••• | Feb 2026 |
|
|
Series B | •••••• | Feb 2026 |
|
|
Post Ipo Equity | •••••• | Jan 2026 |
|
|
Series B | •••••• | Jan 2026 |
Latest News
Alchemab lands £25m from British Business Bank in record life sciences bet
Thenextweb · Jul 09, 2026
All startup & investor data, one platform.
Filter investors by stage, sector, and geography. Compare portfolios side by side. Spot market signals before anyone else.